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Objectives. This study sought to assess the diagnostic implica- 
tions of the flow dependence of Doppler echocardiographic in- 
dexes of aortic valve stenosis. 
Background. Although valve area has been shown to change 
with alterations in flow rate, the diagnostic consequences of this 
phenomenon remain unknown. Valve resistance has been sug- 
gested as a more stable index for evaluating aortic stenosis. 
Methods. A low dose dobutamine protocol was performed in 35 
patients with aortic stenosis. Hemodynamic indexes were obtained 
by Doppler echocardiography atbaseline and at each dobutamine 
dose. 
Results. As a result of the shortening of the systolic ejection 
period, flow increased from (mean -+ SD) 164 _+ 48 to 229 -+ 
102 ml/s (p < 0.0001). At peak flow, valve area increased by 28% 
(from 0.5 -+ 0.2 to 0.6 -+ 0.3 cm 2, p < 0.0001), whereas valve 
resistance decreased by 4% (from 498 -+ 252 to 459 + 222 
dynes.s.cm -5, p = 0.04). This observed change in resistance was 
smaller than that for valve area (p < 0.01). The flow dependence 
of valve area varied among individual patients (p < 0.0001). 
Multivariate analysis identified calcific degenerative etiology 
(beta 0.29, p = 0.002), left ventricular velocity of fiber shortening 
(beta 0.22, p = 0.01), baseline flow (beta -0.28, p = 0.04) and 
amount of flow increase induced by dobutamine (beta 0.90, p < 
0.0001) as factors related to valve area flow dependence. 
Conclusions. Although all Doppler echocardiographic ndexes 
of aortic stenosis are affected by flow, valve resistance is more 
stable than valve area under dobutamine-induced hemodynamic 
changes. Baseline valve area may be unreliable in patients with 
calcific degenerative aortic stenosis and low output states. 
(J Am Coil Cardiol 1996;28:1206-13) 
Valve area is currently accepted as the most useful index for 
assessing the hemodynamic burden imposed by a stenotic 
cardiac valve (1). However, use of the Gorlin method to 
calculate valve area may be unreliable because valve area is 
known to change with alterations in flow (2-7). Moreover, 
valve area derived by Doppler echocardiography hasalso been 
reported to be flow dependent (7-9). These findings have 
stressed the possibility of misdiagnosing aortic stenosis when 
flow rate is low, a phenomenon that has been severally 
designated as flow-dependent, relative or pseudo severe aortic 
stenosis (9-11). In such cases, the pharmacologic ncrease of 
flow has been recommended (9,10) to correctly assess disease 
severity, and preliminary attempts o base clinical decisions on 
these protocols have been reported (9,12). However, several 
issues remain to be defined: 1) Flow dependence of aortic valve 
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area derived by Doppler echocardiography hasbeen confirmed 
only in selected groups of patients with aortic stenosis. 2) It 
remains to be elucidated whether valve area flow dependence 
occurs mainly at low flow states or at all ranges of volumetric 
flow rate. 3) Differences in flow dependence among the 
different varieties of the disease have not been assessed. Aortic 
valve resistance has been proposed (13,14) as an alternative 
index of aortic stenosis because it is expected to remain more 
stable under changing hemodynamic conditions. 
The present study was therefore designed to study the 
effects of dobutamine-induced flow augmentation Doppler 
echocardiographic indexes of aortic valve stenosis in an un- 
selected group of patients with this disease. 
Methods  
The study protocol was approved by our institutional review 
board. Written informed consent was obtained from all pa- 
tients. 
Patients. The study group originally included 57 consecu- 
tive adult patients referred to our echocardiography labora- 
tory, in whom aortic valve stenosis was diagnosed on routine 
ultrasound evaluation (aortic velocity. ->2.5 m/s assessed by 
continuous wave Doppler). Only four exclusion criteria were 
established: 1) a suboptimal echocardiographic window (n = 
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Abbreviations and Acronyms 
CI - confidence interval 
EF = ejection fraction 
= mean systolic transvalvular volume flow 
rate 
V~, = left ventricular heart rate-corrected 
velocity of circumferential fiber shortening 
2); 2) New York Heart Association functional class IV (n = 5); 
3) the presence of major ventricular arrhythmias (n = 1); and 
4) atrial fibrillation (n = 12). Two patients declined to 
participate in the study; therefore, the remaining 35 patients 
form the basis for this report. 
To evaluate the factors related to valve area changes, a 
subgroup of 25 patients with isolated aortic stenosis were 
selected according to the absence of 1) segmental wall motion 
abnormalities (either at baseline or dobutamine induced), 
2) significant mitral stenosis, and 3) mitral or aortic regurgita- 
tion. Clinical characteristics are shown in Table 1. 
Study protocol. A complete Doppler echocardiographic 
examination was performed using a phased-array ultra- 
sound device (Hewlett-Packard Sonos 1500 or 2500) with 
2.5/2.0-MHz duplex and 1.9-MHz (Pedoff) transducers. Best 
quality frames and cardiac cine loops were stored on a digital 
magneto-optical disk for subsequent analysis. Left ventricular 
outflow tract diameter was measured in the parasternal long- 
axis view at the point of insertion of the sigmoid valves. To 
record left ventricular outflow velocity, a 5-mm long pulsed 
Doppler sample volume was located 1cm proximal to the valve 
plane in the apical view and then advanced until spectral 
broadening was detected. Special care was taken to retain 
sample volume location throughout the complete protocol. 
The aortic jet was interrogated with continuous wave Doppler 
from multiple ultrasound views, and the location that showed 
maximal velocity was marked on the patient's chest wall. High 
Table l. Clinical Data for All Patients and Subgroup With Isolated 
Aortic Stenosis 
All Patients Isolated AS 
(n = 35) (n = 25) 
Age (yr)* 7l _+ 14 71 _+ 15 
Range 31- 87 50-87 
Male/female (n) 16/19 9/16 
Etiology, of AS [n (%)] 
Degenerative calcific 25 (71) 19 (76) 
Rheumatic 7 (2(I) 5 (20) 
Bicuspid 3 (9) 1 (4) 
Symptoms [n (%)] 
None 11 (31) 9 (36) 
Angina 9 (26) 5 (20) 
Exertional dyspnea 10 (29) 8 (32) 
Syncope 2 (6) 1 (4) 
Congestive heart failure 7 (20) 5 (20) 
*Median + intcrquartile amplitude. AS = aortic stenosis. 
pass filters were set at 400 Hz for pulsed and at maximum for 
continuous wave Doppler; filters remained unchanged 
throughout the complete protocol. 
Mter the baseline study, a low dose dobutamine infusion 
protocol was begun at 5 /~g/kg body weight per rain up to 
20 p,g/kg per rain, titrated upward at steps of 5 gg/kg per min 
every 5 rain. The dobutamine infusion was ended when the 
maximal dose or 85% of the maximal theoretic heart rate was 
reached; when patients developed yspnea, angina, dizziness 
or hypotension; or when changes in left ventricular segmental 
contractility were detected. Atenolol (2.5 mg intravenously) 
was administrated to all patients who presented symptoms 
during dobutamine infusion. Spectral displays of left ventricu- 
lar outflow tract and aortic stenosis jet velocity were obtained 
within the last 2 rain of each dose. When necessary, progres- 
sion to the next step was delayed until Doppler recordings 
were considered optimal. Blood pressure and the electrocar- 
diogram were monitored noninvasively. 
Data analysis. Two-dimensional nd Doppler echocardio- 
graphic images were evaluated off-line by a single experienced 
echocardiographer (J.B.), using built-in software, calipers and 
the trackball of the echocardiographic equipment used for 
image acquisition. End-diastolic and end-systolic endocardial 
areas (LVA d and LVA~, respectively) were traced from two- 
dimensional parasternal short-axis views. Heart rate-corrected 
mean velocity of circumferential fiber shortening (Vet-) was 
computed from these areas uch that Vet = (LVA o - LVA~)/ 
(EVA d • SEP/V~R-R), where SEP is the systolic ejection period, 
measured as the time between aortic valve opening and closure 
echoes in the aortic Doppler recording. Left ventricular vol- 
umes, ejection fraction and mass were calculated by the 
biplane method of disks (15). Left ventricular outflow tract 
cross-sectional area (CSALvoT) was derived from its diameter 
assuming a circular shape. Three to five consecutive Doppler 
curves of left ventricular outflow tract and aortic velocities 
were traced in the basal state and for each dobutamine dose. 
Systolic time-velocity integrals (TVILvoT, TVIAo ) were then 
averaged. Stroke volume (SV) was calculated as TVILvoT • 
CSAt,vov and mean systolic transvalvular volume flow rate (Q) 
as SV/SEP (16). Mean transaortic pressure gradient (Grad) was 
obtained using the simplified Bernoulli equation. Mean aortic 
valve resistance (AVR) and aortic valve area (AVA) were 
calculated, respectively, asAVR = Grad • 1.333/Q and AVA = 
TVILvoT " CSALvoT/TVlAo (17). To assess intraobserver and 
interobserver variability, 20 patients were randomly selected. 
Their cardiac ine loops of left ventricular outflow diameter and 
baseline Doppler tracings were then remeasured. 
The etiology of aortic stenosis was assumed to be rheumatic 
when coexisting characteristic mitral valve disease was ob- 
served by two-dimensional transthorathic e hocardiography. A 
congenital bicuspid valve was diagnosed in three patients and 
confirmed by identification of only two leaflets and two com- 
missures by multiplane transesophageal chocardiographic ex- 
amination; valve calcification was absent. All other cases were 
considered to be of the calcific degenerative type. 
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Table 2. Absolute and Relative Variability of Indexes of Aortic 
Stenosis Derived by Doppler Echocardiography 
Intraobserver Interobserver 
Variability Variabili~ 
(mean : SD) (mean _+ SD) 
Grad (mm Hg) 5 : 4 8 ± 4 
Grad (%) 9 : 6 14 = 7 
]'VILvoT/q~VIA,, (%) 5 : 6 5 : 6 
AVA (cm 2) 0.07 _- 0.07 0.08 _+ 0.09 
AVA (9~) 14 : ll 18 ± 16 
AVR (dynes.s.cm 5) 88 : 66 100 ± 92 
AVR (~) 18 : 12 21 _+ 17 
AVA = aortic valve area; AVR = aortic valve resistance: Grad = mean 
systolic transaortic pressure gradient: TVILvoT and TVIA, , = Time-velocity 
integrals of left ventricular outflow tract and aorta, respectively. 
Table 3. Baseline Echocardiographic Data for All Patients and 
Subgroup With Isolated Aortic Stenosis 
All Patients Isolated AS 
(n : 35) (n = 25) 
AVA (cm 2) 0.5 ± 0.2 (0.2-1.3) 0.5 ± 0.2 (0.2-1.1) 
AVR (dynes's'cm 5) 498 ± 252 (80-1241) 518 ± 262 (114-1241) 
Grad (ram Hg) 55 : 21 (14-100) 58 _+ 22 (20-100) 
LVEDVI (ml/m 2) 63 _+ 28 (24-170) 59 _+ 22 (24-109) 
V~.f (s 1) 1.3 ± 0.6 (0.2-2.6) 1.4 _+ 0.6 (0.5-2.5) 
Ejection fraction 0.6 ± 0.2 (0.2-0.8) 0.6 ± 0.1 (0.2-0.8) 
LVMI (g/m 2) 154 ± 62 (58-401) 160 _+ 71 (58-402) 
Data presented are mean value _+ SD (range). V~f = left ventricular heart 
rate-corrected mean velocity of circumferential fiber shortening; LVEDVI = left 
ventricular end-diastolic volume index; LVMI = left ventricular mass index; 
other abbreviations as in Table 2. 
Statistical analysis. Results are presented as mean value _+ 
SD, unless otherwise indicated. The regression equation of 
valve resistance was obtained from pooled values from all 
dobutamine doses using Newton-Raphson nonlinear fitting 
(see Appendix). Absolute and relative variabilities of aortic 
stenosis indexes were obtained as previously recommended 
(18) (Table 2). 
Hemodynamic changes were assessed by one-way analysis 
of variance accounting for repeated measures (multivariate 
analysis of variance). Baseline indexes of aortic stenosis were 
compared with those obtained at the dose of peak Q for each 
patient, using Spearman's correlation coefficient and the 
paired t test. Absolute percent of these index changes were 
compared by factorial analysis of variance followed by the 
Tukey-Kramer test. Interindividual differences were assessed 
by least-squares linear regression analysis accounting for re- 
peated measures and different slopes where the dependent 
variable was transformed to its natural logarithm to stabilize 
variance. The association of clinical and hemodynamic factors 
with valve area enlargement was tested using Spearman's 
correlation coefficient. Etiology of aortic stenosis was coded as 
a dichotomous variable, grouping calcific variety as one group 
and rheumatic and congenital s the other. The same variables 
except clinical status were then screened by multivariate 
analysis. The multiple linear regression model was selected 
using the "all subsets regression" procedure focused on the 
best Mallow's conditional mean squared error of production 
criteria (Cp index) (19). Because of the small sample size, 
special care was taken to verify that data met the assumptions 
for multiple regression (19), All statistical analyses were per- 
formed using the JMP statistical software program (Version 
3.0., SAS Institute Inc.), except all subsets regression (BMDP 
Version PC90, BMDP Statistical Software Inc.) and multivar- 
iate analysis of variance (SPSS Version 4.0, SPSS Inc.). A p 
value <0.05 was considered significant. 
Resu l ts  
Clinical response to dobutamine protocol. Baseline echo- 
cardiographic data are shown in Table 3. No major complica- 
tions occurred with dobutamine infusion. Four patients (9%) 
experienced angina, which disappeared <10 min after discon- 
tinuation of dobutamine and the administration f atenolol; all 
four complained of exercise angina. Coronary angiography 
revealed multivessel disease in two of these patients but no 
lesions in the other two. One patient developed an asymptom- 
atic atrial tachycardia that reverted to sinus rhythm after 
atenolol administration, and one had asymptomatic hypoten- 
sion (decrease of 22 mm Hg in systolic arterial pressure). 
End-systolic acceleration at the left ventricular outflow tract 
took place in three patients, leading to discontinuation of
dobutamine before aliasing of the Doppler signal occurred. 
Hemodynamic hanges induced by dobutamine. As shown 
in Figure 1, a strong correlation between valve area and 
resistance was obtained for a given transaortic gradient (r 2 = 
0.99). Figure 2 summarizes the hemodynamic changes induced 
by dobutamine. Cardiac output increased from 3.6 _+ 1.0 
liters/rain at baseline to 5.5 + 2.2 liters/rain at peak dobut- 
amine dose (p < 0.0001 for all dose comparisons). However, 
this change resulted from an increase in heart rate because 
stroke volume remained constant (p = 0.06). Shortening of the 
systolic ejection period resulted in a mean systolic transvalvu- 
lar flow rate increase, from 164 _+ 48 to 229 _+ 103 ml/s (p < 
0.0001). Transvalvular flow rate correlated with the dobut- 
amine dose infused at that moment (r 2 = 0.93, p < 0.0001), but 
the response of flow to dobutamine was different among 
individual patients (p < 0.0001 and p = 0.001 for between 
subjects and between subject-dobutamine dose effects, respec- 
tively). 
Changes in indexes of aortic stenosis induced by dobut- 
amine. Figure 3 shows the changes in aortic stenosis indexes 
induced by dobutamine. Both mean transaortic gradient and 
aortic valve area increased significantly with dobutamine infu- 
sion (p < 0.0001 for both tests). A mean increase of 40% in 
pressure gradient was observed at the dobutamine-induced 
maximal flow (from 55 + 21 to 75 _+ 26 mm Hg, p < 0.0001, 
95% confidence interval [CI] 15 to 25). Compared in the same 
way, valve area increased by 28% (from 0.5 _+ 0.2 to 0.6 _+ 
0.3 cm 2, p < 0.0001, 95% CI 0.1 to 0.2). Multiple-dose 
comparison of valve resistance disclosed no change during 
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Figure 1. Scatterplot of aortic valve area (AVA) and aortic valve 
resistance (AVR) obtained from pooled values from all dobutamine 
doses. The regression curves obtained for aortic valve area and 
aortic valve resistance are shown for different values of mean 
transaortic pressure g~adient (Grad) and were obtained from the 
relation AVR = 28~/~/AVA.  See Appendix for details. 
dobutamine infusion (p = 0.6) (Fig. 3). However, a small 
decrease in valve resistance was observed at the dose of peak 
flow (mean 4%; from 498 _+ 252 to 459 _+ 222 dynes.s.cm s, 
p = 0.04, 95% CI 2 to 76). Changes in the group with isolated 
aortic stenosis were similar: Gradient increased by 42% (from 
57 + 22 to 79 -+ 25 mm Hg, p < 0.0001, 95% CI 16 to 26) and 
valve area by 31% (from 0.4 _+ 0.2 to 0.6 +_ 0.3 cm 2, p < 0.0001, 
95% CI 0.1 to 0.2), but resistance did not change significantly 
(from 518 _+ 263 to 476 _+ 236 dynes.s.cm 5, p = 0.08). 
Values at baseline and at maximal flow closely correlated, 
both for valve area and resistance (rho 0.85 and 0.87, respec- 
tively). The mean absolute percent change in valve resistance 
observed between baseline and peak flow values was smaller 
than that for mean gradient and valve area (p < 0.0001 and 
p < 0.01, respectively); no difference was observed between the 
latter two indexes (p > 0.05) (Fig. 4). 
Two patients howed a small valve area (-<0.7 cm 2) and a 
low gradient (---35 mm Hg) at baseline study. One patient had 
associated chronic arterial hypertension and was asymptom- 
atic; although her left ventricular function was not impaired 
(ejection fraction [EF] 0.7, V~f = 1.4/s), both cardiac index and 
transvalvular flow were low (cardiac index 1.7 liters/min 
per me; Q = 190 ml/s). Dobutamine infusion increased flow by 
85%, enlarging valve area by 60% (from 0.4 to 0.7 cm 2) and 
decreasing resistance by 26% (from 354 to 261 dynes.s.cm-5). 
The other patient had heart failure and left ventricular dysfunc- 
tion (EF = 0.3; V~f = 0.8/s; cardiac index 0.9 liters/min per me; 
Q= 59 ml/s). Dobutamine up to 20 ~tg/kg per rain induced no 
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Figure 2. Scatterplot of hemodynamic variables at baseline and peak 
dobutamine dose. Values above the identity line (thin line) represent 
an increase in the hemodynamic variable from baseline to peak 
dobutamine dose; values below this line represent a decrease. The 
thick line has the same slope as the identity line but is displaced by the 
difference in the mean values; dashed lines represent the 95% CI for 
this mean difference• The lack of increase in stroke volume at peak 
dobutamine dose is represented by the inclusionof the identity line 
within the dashed lines. CO = cardiac output; Q = mean systolic 
transvalvular flow rate; SV = stroke volume. 
relevant change in either flow (6%) or valve area (6%; from 0.2 
to 0.2 cm2); resistance increased by 15% (from 697 to 801 
dynes.s.cm 5). 
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Figure 3. Scatterplot of hemodynamic indexes of aortic stenosis at 
baseline and at peak mean systolic transvalvular flow rate. Intcrindi- 
vidual differences in the amount of change induced by dobutamine in 
a specific index (i.e., aortic valve resistance) can be observed because 
patients with similar values at baseline disclose a wide range of values 
at peak Q. Grad = mean systolic transaortic pressure gradient; 
symbols and other abbreviations as in Figures 1 and 2. 
Interindividual variability of valve area flow dependence. 
A strong correlation was observed between aortic valve area 
and transvalvular flow rate at each dobutamine dose in the 
same patient (r 2 = 0.98, p < 0.0001); however, the level of 
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Figure 4. Mean (SE) absolute percent changes [A(%)] in indexes of 
aortic stenosis observed from baseline to the dobutamine dose pro- 
ducing maximal mean systolic transvalvular flow rate. *p < 0.01 for 
Tukey-Kramer comparison test. Abbreviations as in Figure 1. 
dependence varied among patients (p < 0.0001 and p = 0.006 
for the between patients and between patient.flow rate effects, 
respectively). 
Factors related to aortic valve area increase. Variables 
related to valve area increase are shown in Table 4. By 
multivariate analysis, the amount of flow augmentation in- 
duced by dobutamine was the most important factor related to 
orifice enlargement (beta 0.90), followed by calcific etiology of 
the disease (beta 0.29), Vcf (beta 0.22) and baseline flow rate 
(beta -0.28). 
D iscuss ion  
Flow dependence of aortic valve area. Flow dependence of 
aortic valve area has been reported in several in vitro (20), 
animal (7) and clinical studies, both for the Gorlin (2-6) and 
Doppler echocardiographic (5,8,9) methods of estimating 
valve area. In the largest Doppler echocardiographic study 
reported, Burwash et al. (8) calculated aortic valve area at 
baseline and after maximal treadmill exercise in asymptomatic 
patients with aortic stenosis. They reported a mean valve area 
enlargement of 14%, parallel to a 24% increase in transvalvu- 
lar flow. The present study demonstrated that dobutamine may 
also increase continuity equation-derived valve area in un- 
selected patients. By increasing heart rate and shortening the 
ejection period, dobutamine increased transvalvular flow and 
induced a 28% increase in valve area. Two small clinical 
studies (5,9) have assessed the effects of dobutamine on 
Doppler echocardiographic valve area, and pooled data from 
these two studies (total 24 patients) reveal changes in valve 
area consistent with our findings. 
The present study showed that valve area may increase with 
no modification of stroke volume. The basis for this finding is 
that, rather than volume, the forces that promote valve aper- 
ture are mediated by flow rate (volume of blood per second of 
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Table 4. Univariate and Multivariate Variables Related to Absolute Valve Area Increase inSubgroup 
With Isolated Aortic Stenosis* 
Multivariate Analysis 
Univariate Analysis Coefficient Standardized Coefficient 
Rho p Value (b) (beta) p Value 
Symptomatic status 
Dyspnea, angina or syncope 0.3 0.1 
Etiology. of AS 
Calcific degenerative 0.03 0.9 0.1 0.29 0.002 
Indexes of LV function 
Ejection fraction 0.3 0.02 
V~t 0.5 0.11 0.[16 0.22 0.0l 
LV mass index 0.5 0.01 
Hemodynamic factors 
Baseline cardiac output 0.2 0.3 
Baseline Q 0.2 0.3 -0.0008 0.28 0.04 
Baseline AVA 0.3 0.1 0.13 0.19 0.2 
Baseline AVR -0.4 0.07 
Baseline Grad -0.2 0.33 
Dobutaminc-induced ~Q 0.9 <0.0001 0.002 0.90 <0.0001 
*Multiple regression model selected by "'all subsets regression" procedure based on the best Mallow's conditional 
mean squared error of prediction (Cp index) (r 2 = 0.91, SE 0.05 cm 2, p < 0.0001 for the whole model). LV - left 
ventricular; Q - mean systolic transvalvular volume flow rate; A change in; other abbreviations as in Tables 1 to 3. 
ejection). As observed in our study, pharmacologic nterven- 
tions were able to increase flow rate and induce aortic enlarge- 
ment only by shortening ejection time. Exercise, by the same 
mechanism, is known to increase valve area even though it 
reduces troke volume in patients with aortic stenosis (8,21- 
23). Shortening of the ejection period is reflected by an 
increase in continuity equation-based valve area because the 
aortic integral (denominator) is reduced, with no change in 
stroke volume (numerator). 
Comprehensive assessment of the hemodynamic principles 
on which the Gorlin and continuity equation methods are 
based has led to the interpretation of the flow-mediated 
changes in valve area as variations in the anatomic orifice and 
not as artifacts of the computation formulas (8,24). Hence, it is 
the degree of true obstruction that seems to be flow depen- 
dent. However, valve area obtained by planimetry of the aortic 
orifice by means of transesophageal chocardiography as 
been shown (25) to remain constant under hemodynamic 
changes. We believe that a possible explanation for this 
discrepancy may be due to conceptual differences between 
anatomic and effective areas. Anatomic vah'e area, as assessed 
by planimetry, accounts for the maximal mid-end-systolic area 
at a precise moment in the heart cycle (26). Effective valve area, 
as assessed by indirect hemodynamic methods, accounts for 
pansystolic functional area, averaged throughout the complete 
ejection period (27,28). Thus, dobutamine-induced hanges in 
effective area may be due to a change in the timing of maximal 
leaflet opening because l aflet inertia may be overcome arlier 
when flow is augmented. 
Our study corroborates the strong linear correlation be- 
tween transvalvular flow and valve area in an individual 
patient, which was demonstrated invasively in a canine model 
of chronic aortic stenosis (7). Remarkably, the grade of flow 
dependence varied from one patient to another (Fig. 3), which 
demonstrates the influence of individual factors on the orifice 
enlargement reserve. Multivariate analysis identified baseline 
flow, left ventricular function and type of disease as the factors 
related to the increase in valve area once the effect of 
augmentation was considered. By univariate analysis, no single 
variable was able to predict he increase in valve area. This 
result was probably due to the interindividual differences 
observed in the flow response to dobutamine. 
The appearance of an association between area enlarge- 
ment and calciflc degenerative etiology of aortic valve stenosis 
suggests a role for the physical characteristics of the valve in 
modulating valve aperture. Because commisural fusion is 
absent, leaflet inertia is one of the principal mechanisms of 
orifice reduction in calcific degenerative aortic stenosis; there- 
fore, this type of disease may be especially prone to flow 
variations (11,29-31). 
The increase in valve area was inversely related to baseline 
flow, a finding in accordance with the concept of flow- 
dependent aortic stenosis. In vitro video recordings of the 
opening of aortic valves have demonstrated (20) that valve 
orifice is flow dependent mainly at flow rates <3 liters/min. 
However, Burwash et al. (8) observed no difference in orifice 
enlargement between patients with and without depressed 
cardiac output. As formerly stated, this discrepancy may be due 
to the type of analysis performed because univariate compar- 
isons cannot account for the confounding effect of flow re- 
sponse to dobutamine. A direct correlation was also observed 
between the increase in valve area and left ventricular velocity 
of circumferential fiber shortening. Because this index is 
strongly affected by systolic wall stress in aortic stenosis, such 
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an association could be due to the effect of valve stiffness on 
ventricular afterload (32). 
Flow dependence of valve resistance. Valve resistance was 
more stable than area when flow was increased, a finding 
consistent with previous observations (33,34). Because of the 
hydraulic models from which each index is derived, it is not 
possible for valve area and resistance to remain constant at a 
time (see Appendix). Area is based on Torricelli's principle of 
laminar flow through a flat orifice in which gradient is propor- 
tional to the square of flow [Grad = f(~2)]. However, resis- 
tance assumes a linear relation between these variables 
[Grad= f(Q)]. Recent investigations (35) have further pro- 
posed a quadratic flow-gradient relation [Grad = f(~2 + ~)]. 
The demonstration f flow-mediated orifice variability suggests 
that the hemodynamic load imposed by aortic valve stenosis 
may be inadequately evaluated if patients are studied only at 
baseline; hence, searching for a flow-independent index of 
severity would be inappropriate. 
Other than increasing transaortic gradient, the main hemo- 
dynamic effect of dobutamine was to shorten the systolic 
ejection period. This variable constitutes a term of the formula 
for valve resistance and by compensating the increase in 
gradient, may explain why resistance remained fairly stable. To 
prove the flow stability of this index, corroboration of our 
results by interventional methods that increase flow without 
modifying the ejection period would be necessary. 
Study limitations. Calculation of hemodynamic indexes by 
Doppler echocardiography is known to be subject to several 
methodologic limitations, such as underestimation f stenotic 
jet velocity and overestimation of proximal velocity. The 
following four precautions were taken to minimize these 
errors: 1) The study was designed to calculate orifice enlarge- 
ment as the change from baseline to dobutamine-induced 
maximal flow rate rather than dobutamine-induced maximal 
area. 2) The position of the Doppler transducer and sample 
volume were maintained throughout the protocol. 3) Dobut- 
amine dose increase was delayed until Doppler recordings 
were considered optimal. 4) Only the highest quality signals 
were selected for analysis. However, because valve area and 
transvalvular flow rate were derived from the same Doppler 
echocardiographic data, their correlation may have been over- 
estimated. 
The observed change in valve area may seem nonsignificant 
because it is almost within the confidence interval of the 
variability of the method (Table 2). However, most such 
variability is due to measurement of the outflow tract diameter. 
This variable is assumed to be anatomically fixed and therefore 
unrelated to the effect of flow. Because only measurement of
velocity curves and systolic ejection period was repeated for 
each dose, variability of Doppler echocardiographic indexes in 
the same patient was considerably reduced (Table 2). 
Clinical implications. The mean change observed for valve 
area was 20% and may seem clinically irrelevant. Yet, the 
observation of an inverse correlation between baseline flow 
and orifice enlargement emphasizes the importance of such a 
finding because patients with aortic stenosis and low cardiac 
output are known to have a poor prognosis during and after 
valve replacement (36,37). Consequently, correct assessment 
of the severity of stenosis is mandatory (38). The present study 
suggests that in these patients, a flow-dependent underestima- 
tion of valve area is likely. Initial experience with clinical 
decisions based on dobutamine protocols is satisfactory 
(9,12,39). Whether valve resistance or flow-mediated changes 
in hemodynamic ndexes can provide new, clinically relevant 
information in terms of outcome and timing of valve replace- 
ment remains unknown. Longitudinal studies to evaluate the 
superiority of these alternative assessments of aortic stenosis 
are therefore warranted. 
Appendix 
Derivation of Aortic Valve Area-Valve 
Resistance Relation 
On the basis of the definition formulas of both aortic valve area (AVA) 
and aortic valve resistance (AVR)--AVA = Q/k~ and AVR = 
Grad/Q. 1.33--a new constant may be substituted for 1.33/k such that 
AVR = aV~/AVA ~ 28 ~/AVA,  where the value a ~ 28 is 
obtained by nonlinear regression analysis of our pooled data (asymp- 
totic 95% CI 27.81 to 28.01, n = 175, r2 = 0.99). By this equation, valve 
resistance can be accurately calculated from area and gradient without 
knowledge of the systolic ejection period. The equation also demon- 
strates why area must increase as gradient increases for resistance to 
remain constant. 
We are indebted to Mercedes Diaz, RN, Carmen AlluG, RN, Paz G6mez- 
Moreno, RDMS and Pablo Puerta, RDMS for technical ssistance. 
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